Dimethyl sulfoxide-caused changes in pro- and anti-angiogenic factor levels could contribute to an anti-angiogenic response in HeLa cells

Dimethyl sulfoxide (DMSO) is widely used in biological research as a general solvent. While it has been previously demonstrated that DMSO possesses a wide range of pharmacological effects, there is no published work regarding the effects of DMSO on pro-angiogenic factor levels. This study was designed to investigate the possible effects of DMSO on the levels of three pro-angiogenic factors released from HeLa cells in vitro. Cells were treated with two different and previously determined concentrations of DMSO. The cytotoxic effects of DMSO concentrations on HeLa cells were determined via MTT. Survival rates of DMSO-treated cells were determined by Invitrogen live/dead viability/cytotoxicity kit and trypan blue exclusion assay. Changes in the pro-angiogenic levels in media were evaluated by Cayman's Substance P Enzyme Immunoassay ELISA kit. Vascular endothelial growth factor ELISA kit and interferon gamma ELISA kit for substance P, VEGF and IFN gamma respectively. Changes in substance P levels were corrected by standard western blotting. Changes in VEGF and IFN gamma levels were corrected both by western blot and real time PCR. Treatment with 1.4 mu M DMSO caused a time-dependent inhibition of cell proliferation at 24,48 and 72 h. 1.4 mu M DMSO caused a significant reduction in VEGF levels at 72 h of incubation and sharp increases in IFN gamma levels at both 48 and 72 h of incubation, According to real time PCR analyses, DMSO (1.4 mu M) exhibited an inhibitory effect on VEGF but acted as an augmenter of IFN gamma release on HeLa cells in vitro. This is the first report showing that the general solvent DMSO suppressed HeLa cell proliferation, decreased the levels of two pro-angiogenic factors (substance P and VEGF) and increased the release of an anti-angiogenic factor IFN gamma in vitro. (C) 2015 Elsevier Ltd. All rights reserved.